Technology

Acer

$3.67
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.05 (-1.34%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Acer and other stocks, options, and ETFs commission-free!

About ACER

Acer Therapeutics Inc. Common Stock (DE), also called Acer, is a pharmaceutical company. The firm engages in the acquisition, development and commercialization of therapies for medical needs. Its product pipeline includes Edsivo and ACER-001. The Edsivo is a type of celiprolol for Vascular Ehlers-Danlos syndrome. The ACER-001 is for the treatment of urea cycle disorders and Maple Syrup Urine diseases. The company was founded by Christopher Schelling on September 19, 2017 and is headquartered in Newton, MA. The listed name for ACER is Acer Therapeutics Inc. Common Stock (DE).

CEO
Christopher Schelling
Employees
17
Headquarters
Newton, Massachusetts
Founded
2017
Market Cap
53.00M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
3.56M
High Today
$3.80
Low Today
$3.39
Open Price
$3.59
Volume
590.89K
52 Week High
$7.25
52 Week Low
$1.08

Collections

ACER Earnings

-$1.09
-$0.73
-$0.36
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 18, After Hours

You May Also Like

EWM
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure